Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 576-600 of 2,022
RecruitingISRCTN23197625

The effects of reducing worry in patients with persecutory delusions: finding out if worries can be reduced by brief cognitive therapy

This study is looking at whether 1 can help people with Persecutory delusions in the context of schizophrenia or related diagnosis, Mental and Behavioural Disorders, or Schizophrenia or related diagnosis. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)
Condition
Schizophrenia
RecruitingISRCTN71305621

Optimising individualised prescribing with therapeutic drug Monitoring for Antipsychotics (OptIMA) 2: clinical pilot study of antipsychotic drug level monitoring

This study is looking at whether Medication decisions will be made by the participant's own clinician can help people with Schizophrenia, schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Institute of Psychiatry, Kings College London (UK)
Condition
Schizophrenia
RecruitingISRCTN60687844

A pilot study of cognitive enhancer and cognitive training combination: testing a therapeutic paradigm for cognitive impairment in schizophrenia

This study is looking at whether The study is a randomised control trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London (KCL) (UK)
Condition
Schizophrenia
RecruitingISRCTN71943786

ENhancing DElivery And outcomes of VOcational Rehabilitation

This study is looking at care and outcomes for people with psychosis. Taking part may give some people access to 1, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom
Sponsor
Kings College London (KCL) (UK)
Condition
Schizophrenia
RecruitingISRCTN59501939

Cognitive mechanisms of change in delusions

This study is looking at whether 1 can help people with psychosis. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Kings College London (KCL) (UK)
Condition
Schizophrenia
RecruitingISRCTN68824876

Amisulpride augmentation in clozapine-unresponsive schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London (UK)
Condition
Schizophrenia
RecruitingISRCTN55488371

Computerised Cognitive Remediation Therapy for Schizophrenia

This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN25898179

Rehabilitation Effectiveness for Activities for Life

This study is looking at whether Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 can help people with psychosis. Participants take part in Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 and complete follow-up assessments.

SchizophreniaOther
Countries
United Kingdom
Sponsor
University College London (UK)
Condition
Schizophrenia
RecruitingISRCTN42412532

Treatment Of Cognitive deficits in schizophrenia with Tolcapone And Pergolide

This study is looking at whether TOCTAP is a randomised, three-armed double-blind study with 60 patients suffering from schizophrenia, using DSM-IV diagnostic criteria can help people with Schizophrenia, cognitive functions, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
Germany
Sponsor
RWTH Aachen University (Germany)
Condition
Schizophrenia
RecruitingISRCTN84216587

Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London and Barts and the London NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN32434568

OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Finland, Italy
Sponsor
University of Oxford (UK)
Condition
Schizophrenia
RecruitingISRCTN94846422

An intervention to improve psychiatrist-patient communication

This study is looking at whether a digital support tool can help people with Schizophrenia/schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Queen Mary University of London (UK)
Condition
Schizophrenia
RecruitingISRCTN74919979

Information technology in mental health

This study is looking at a support or therapy approach for people with Schizophrenia, schizotypal disorders or delusional disorders, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Finland
Sponsor
Academy of Finland (Finland)
Condition
Schizophrenia
RecruitingISRCTN54975957

Mirtazapine augmentation enhances cognitive and negative symptoms in schizophrenic patients treated with risperidone: a randomised controlled trial

This study is looking at whether Mirtazapine was added to the on-going pharmacotherapy with risperidone in the mirtazapine group can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther
Countries
South Korea
Sponsor
Bundang CHA Hospital (South Korea)
Condition
Schizophrenia
RecruitingISRCTN61794329

Does oral N-acetyl-cysteine (NAC) improve schizophrenia symptoms?

This observational study is following people with Early phase psychosis, Mental and Behavioural Disorders, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOther
Countries
Switzerland, United States
Sponsor
Swiss National Science Foundation (Fonds National Suisse de la Recherche Scientifique [SNSF]) (Switzerland)
Condition
Schizophrenia
RecruitingISRCTN56877013

A randomised trial comparing the clinical and cost effectiveness of usual, facility based care compared to an additional collaborative community care package for people and their families living with schizophrenia in India

This study is looking at whether a digital support tool can help people with Mental health/schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, India
Sponsor
Kings College London (UK)
Condition
Schizophrenia
RecruitingISRCTN50247539

Reflex

This study is looking at whether Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist can help people with Psychic disorders, schizophrenia and other psychosis, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen (UMCG) (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN64695913

Safety and efficacy trial of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)

This study is looking at whether There is a 14-day screening period and a 3 to 7-day placebo washout period before randomisation of the participants for the trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years
Countries
Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN44297014

A phase III randomised, double-blind, active comparator-controlled clinical trial to study the safety and efficacy of lurasidone in subjects with schizophrenia (PEARL 3 extension study)

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia